# Innovative Technologies in Restoring Gait and Balance Funtions in Ischemic Stroke Patients at the Inpatient Stage

Study · id `cardio:ct-nct05423626` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05423626](<https://clinicaltrials.gov/study/NCT05423626>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05423626

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT05423626. Randomized; single masking; primary purpose treatment. Start 2022-03-18 (actual); primary completion 2023-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT05423626, source copy `cardio:ctgov-nct05423626-2022-06-21`, retrieved 2026-10-26)
- Started: 2022-03-18 (actual) (ClinicalTrials.gov record NCT05423626, source copy `cardio:ctgov-nct05423626-2022-06-21`, retrieved 2026-10-26)
- Primary completion: 2023-12-31 (anticipated) (ClinicalTrials.gov record NCT05423626, source copy `cardio:ctgov-nct05423626-2022-06-21`, retrieved 2026-10-26)
- Completion: 2023-12-31 (anticipated) (ClinicalTrials.gov record NCT05423626, source copy `cardio:ctgov-nct05423626-2022-06-21`, retrieved 2026-10-26)
- Countries: Russia (ClinicalTrials.gov record NCT05423626, source copy `cardio:ctgov-nct05423626-2022-06-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05423626-2022-06-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Innovative Technologies in Restoring Gait and Balance Funtions in Ischemic Stroke Patients at the Inpatient Stage
- Condition: Ischemic Stroke, Acute
- Intervention (Device): technologies of robotic mechanotherapy with FES
- Intervention (Device): biofeedback virtual reality technologies
- Lead sponsor: Moscow Scientific and Practical Center of Medical Rehabilitation, Restorative and Sports Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: ffebc648d003c1219f275266366836dc0d78abee62f8c6c14b4ef1b8a9faa453
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
